Dr Sarah Essilfie-Quaye is Project Manager in the Research Strategy Team, Faculty of Medicine, Imperial College London.
She works closely with Dr Des Walsh (Director of Research Strategy), Dr Shona Blair (Head of Research Strategy) and Dr Kimberley Trim (Research Strategy Coordinator).
In her current role, Sarah is the first point of contact for queries pertaining to the Wellcome Trust Institutional Strategic Support Fund (ISSF).
For ISSF enquiries please email ISSF@imperial.ac.uk
Sarah is also the Communications and Events Manager for Imperial As One, Imperial College London’s staff network for BME and Race. Imperial As One is working to support and promote an inclusive workplace culture of respect, opportunity, unity, transparency and equality.
et al., 2016, Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD., Chest, Vol:149, ISSN:1931-3543, Pages:62-73
et al., 2013, Inhaled long-acting beta(2) agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD, Journal of Allergy and Clinical Immunology, Vol:132, ISSN:0091-6749, Pages:1166-1173
et al., 2011, Comparison of Symbicort (R) versus Pulmicort (R) on steroid pharmacodynamic markers in asthma patients, Respiratory Medicine, Vol:105, ISSN:0954-6111, Pages:1784-1789
et al., 2015, LSC Abstract - Rhinovirus infection induces NRF2 in monocytes but not in epithelial cells, via distinct intracellular pathways, EUROPEAN RESPIRATORY SOC JOURNALS LTD, ISSN:0903-1936
et al., 2013, HDAC ACTIVITY IN MACROPHAGES IN EXPERIMENTAL RHINOVIRUS INFECTION IN COPD, Winter Meeting of the British-Thoracic-Society, BMJ PUBLISHING GROUP, Pages:A58-A59, ISSN:0040-6376